|
OMIM |
Link |
Information gain |
01 |
|
HBFQTL2
|
[NCBI]
|
0.00880198
|
|
|
HBB
|
[NCBI]
|
0.00834335
|
|
|
HBA1
|
[NCBI]
|
0.00205594
|
|
|
HBA2
|
[NCBI]
|
0.00130568
|
|
|
HBD
|
[NCBI]
|
0.00125437
|
|
|
HBFQTL1
|
[NCBI]
|
0.00101809
|
|
|
HBG1
|
[NCBI]
|
0.000722175
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
0.000691899
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
0.000631095
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
0.000576525
|
|
|
ATRX
|
[NCBI]
|
0.000549194
|
|
|
CBBM
|
[NCBI]
|
0.000486675
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
0.000420224
|
|
|
HBZ
|
[NCBI]
|
0.000387663
|
|
|
sickle cell anemia
|
[NCBI]
|
0.00038223
|
|
|
MAFD1
|
[NCBI]
|
0.000347532
|
|
|
G6PD
|
[NCBI]
|
0.000347514
|
|
|
HBG2
|
[NCBI]
|
0.000237612
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
0.000199
|
|
|
MRXHF1
|
[NCBI]
|
0.000194814
|
|
|
anemia, microcytic
|
[NCBI]
|
0.000168085
|
|
|
VEGF
|
[NCBI]
|
0.000165145
|
|
|
TNF
|
[NCBI]
|
0.000143442
|
|
|
locus control region, alpha
|
[NCBI]
|
0.000118252
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
0.000118252
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000105181
|
|
|
nephropathy with pretibial epidermolysis bullosa and deafness
|
[NCBI]
|
9.2402e-05
|
|
|
ATMDS
|
[NCBI]
|
8.39333e-05
|
|
|
raph blood group system
|
[NCBI]
|
8.39333e-05
|
|
|
polydactyly, postaxial
|
[NCBI]
|
8.39333e-05
|
|
|
tuftsin deficiency
|
[NCBI]
|
7.4356e-05
|
|
|
angioid streaks
|
[NCBI]
|
7.4356e-05
|
|
|
australia antigen
|
[NCBI]
|
7.11054e-05
|
|
|
HGPPS
|
[NCBI]
|
6.84045e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
6.58485e-05
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
6.22847e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
6.22847e-05
|
|
|
THC1
|
[NCBI]
|
5.78732e-05
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
5.66385e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
5.4425e-05
|
|
|
xanthinuria, type i
|
[NCBI]
|
5.4425e-05
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
5.4425e-05
|
|
|
ACHM2
|
[NCBI]
|
5.4425e-05
|
|
|
EL1
|
[NCBI]
|
4.92003e-05
|
|
|
CF
|
[NCBI]
|
4.56512e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
4.52907e-05
|
|
|
ABCA1
|
[NCBI]
|
4.52859e-05
|
|
|
PRL
|
[NCBI]
|
4.16335e-05
|
|
|
FIH
|
[NCBI]
|
4.08221e-05
|
|
|
TSTA3
|
[NCBI]
|
4.01825e-05
|
|
|
locus control region, beta
|
[NCBI]
|
4.01825e-05
|
|
|
OCA1A
|
[NCBI]
|
3.84358e-05
|
|
|
HBE1
|
[NCBI]
|
3.68306e-05
|
|
|
HBQ1
|
[NCBI]
|
3.68306e-05
|
|
|
NFE2
|
[NCBI]
|
3.68306e-05
|
|
|
fructosuria
|
[NCBI]
|
3.43449e-05
|
|
|
RHD
|
[NCBI]
|
2.81119e-05
|
|
|
TERT
|
[NCBI]
|
2.70792e-05
|
|
|
HK1
|
[NCBI]
|
2.70311e-05
|
|
|
MN
|
[NCBI]
|
2.60614e-05
|
|
|
ACP1
|
[NCBI]
|
2.60614e-05
|
|
|
PTH
|
[NCBI]
|
2.42838e-05
|
|
|
DBA
|
[NCBI]
|
2.24739e-05
|
|
|
CRP
|
[NCBI]
|
2.1722e-05
|
|
|
KL
|
[NCBI]
|
2.1722e-05
|
|
|
GATA1
|
[NCBI]
|
1.87942e-05
|
|
|
NDP
|
[NCBI]
|
1.45985e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.41057e-05
|
|
|
ATRX
|
[NCBI]
|
1.36411e-05
|
|
|
PXE
|
[NCBI]
|
1.36233e-05
|
|
|
ACHE
|
[NCBI]
|
1.15769e-05
|
|
|
SLC4A1
|
[NCBI]
|
1.0231e-05
|
|
|
WAS
|
[NCBI]
|
1.00143e-05
|
|
|
HS
|
[NCBI]
|
9.41645e-06
|
|
|
EPO
|
[NCBI]
|
8.87542e-06
|
|
|
CVID
|
[NCBI]
|
8.66178e-06
|
|
|
CFTR
|
[NCBI]
|
8.323e-06
|
|
|
HPRT1
|
[NCBI]
|
5.72971e-06
|
|
|
PF4
|
[NCBI]
|
4.71501e-06
|
|
|
HMBS
|
[NCBI]
|
4.43961e-06
|
|
|
ADA
|
[NCBI]
|
3.72052e-06
|
|
|
APOB
|
[NCBI]
|
8.25415e-07
|
|
|
DHFR
|
[NCBI]
|
3.91458e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.628e-09
|
|